While issuance of high yield bonds strengthened across all key global jurisdictions in 2024, the US and Europe still face mounting maturity walls -
High yield bond issuance in key markets around the world recorded major...more
High yield activity in the US, Europe and APAC revives after a tricky period, but markets remain uncertain moving into the final months of 2024
High yield bond issuance across the US, Europe and APAC rallied in H1 2024....more
The high yield bond markets in the US and Europe sprang back to life in Q1 2024, with issuance showing strong gains after a slow 2023.
US high yield bond issuance for Q1 2024 came in at US$68.6 billion, almost doubling...more
Lenders and borrowers in US leveraged finance markets have had to recalibrate pricing and issuance volume expectations in 2022 in the face of rising inflation and interest rates....more
Following a year of healthy activity, M&A deals in the pipeline are set to sustain leveraged finance issuance in the pharmaceutical, medical and biotech sector in the months ahead -
Lender appetite for exposure to the...more
2/9/2022
/ Acquisitions ,
Biotechnology ,
Borrowers ,
Capital Markets ,
Coronavirus/COVID-19 ,
Environmental Social & Governance (ESG) ,
Financial Services Industry ,
Global Market ,
Healthcare ,
High Yield Bonds ,
Lenders ,
Leveraged Loans ,
Mergers ,
Pharmaceutical Industry
High yield issuance across major global markets made steady gains in the first nine months of 2021 in most regions, as investor appetite for yield supported stable activity through the year.
In the US, high yield issuance...more
Plentiful liquidity supports a year-on-year rise in high yield bond issuance in the US, Europe and the Asia-Pacific region - High yield bond markets posted strong gains in the US, Europe and the Asia Pacific region (excluding...more